Description
Wolverine Blend is a research formulation combining two peptides frequently studied together in preclinical tissue-repair and recovery models: BPC-157, a pentadecapeptide investigated for cytoprotective and angiogenic activity, and TB-500, a fragment of thymosin beta-4 studied for actin regulation and cell migration. It is provided as a combined tool preparation for investigating their interacting signaling endpoints in experimental designs.
Wolverine Blend has been examined in preclinical in vitro and rodent model studies of angiogenesis, cell migration, extracellular matrix remodeling, inflammatory signaling, and wound-healing dynamics. Its combined formulation supports comparative and additive-effect research across the tissue-repair pathways associated with its constituent peptides in cell-based and rodent models.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.







Reviews
There are no reviews yet.